Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Docefect-RTU 80mg Injection

Prescription Icon
Prescription Required

Marketer

Aureate Healthcare Pvt Ltd

Salt Composition

Docetaxel (80mg)

Overview Docefect-RTU 80mg Injection

Docefect-RTU 80mg Injection, an antineoplastic agent, treats breast, non-small cell lung, prostate, and head and neck cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and fatigue. Your doctor may prescribe additional medications to mitigate these. Report any unexplained bleeding or bruising, sore throat, mouth sores, or fever immediately. This medication can reduce blood cell counts (red and white), increasing infection risk; regular blood tests are mandatory to monitor blood cell levels and liver function. Prior to treatment, inform your doctor of any heart, liver, or kidney conditions, or concurrent medications, especially anti-infectives. Interactions with other drugs are possible; disclose all medications. This injection is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout treatment.

Uses of Docefect-RTU 80mg Injection

Cancers affecting the breast, lungs (non-small cell), prostate, and head/neck.

Major Benefits of Docefect-RTU 80mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Docefect-RTU 80mg Injection:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use Docefect-RTU 80mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

How Docefect-RTU 80mg Injection works:

Docefect-RTU 80mg Injection is an antineoplastic agent. Its mechanism of action involves disrupting microtubule networks, essential for cancer cell division and proliferation. This inhibition of cellular growth ultimately leads to cancer cell death.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Docefect-RTU 80mg Injection is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Docefect-RTU 80mg Injection during pregnancy carries established risks to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential advantages outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Administering Docefect-RTU 80mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm due to the drug's toxicity.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Docefect-RTU 80mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Docefect-RTU 80mg Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.

LiverLiverCAUTION

The use of Docefect-RTU 80mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Docefect-RTU 80mg Injection might be necessary. Physician consultation is advised.

What if you forget to take Docefect-RTU 80mg Injection :

NA

Facts to Know About Docefect-RTU 80mg Injection

LabelValue
Type of Compound Taxane-based medications
Potential for Dependence None.
Type of Treatment Cancer-fighting drugs
Mechanism of Action Microtubule-targeting drugs: Taxane class

FAQs on Docefect-RTU 80mg Injection

Indeed, Docefect-RTU 80mg Injection can lead to weight increase. This is often a consequence of fluid buildup, potentially starting with swollen feet before affecting the entire body. Contact your physician promptly if you experience foot swelling.
Maintain Docefect-RTU 80mg Injection administration according to your physician's instructions. Treatment length depends on your specific cancer and individual response. Infusions are typically given every three weeks.
Docefect-RTU 80mg Injection contains alcohol, potentially causing drowsiness, dizziness, confusion, and impaired coordination, mimicking alcohol intoxication. Operating machinery or driving immediately following administration is therefore unsafe. Concurrent alcohol consumption during Docefect-RTU 80mg Injection treatment should be strictly avoided due to the risk of negative interactions.
Docefect-RTU 80mg Injection is a treatment option for breast cancer, specific lung cancers, prostate cancer, stomach cancer, and cancers of the head and neck. Its mechanism of action involves inhibiting cellular growth and proliferation.
Docefect-RTU 80mg Injection is administered intravenously as a liquid solution by healthcare professionals in a clinical setting. The typical dosage regimen involves a single injection over a 60-minute period, repeated every 21 days.
Before each Docefect-RTU 80mg Injection, your physician will require blood work. This includes tests like a complete blood count and liver function panel to monitor blood cell levels and liver health, ensuring suitability for the injection. Low white blood cell counts can lead to fever or infections.
Docefect-RTU 80mg Injection can cause hair loss, a frequent adverse reaction. Hair regrowth typically occurs following discontinuation of Docefect-RTU 80mg Injection. Nevertheless, permanent hair loss is possible. Seek medical advice for any hair loss-related worries.
Administration of Docefect-RTU 80mg Injection can lead to edema (swelling in the extremities) and serious allergic responses. Prophylactic corticosteroids (dexamethasone) are prescribed for three days, commencing one day before Docefect-RTU 80mg Injection is given, to mitigate these risks. For patients with metastatic castration-resistant prostate cancer, dexamethasone is administered orally at twelve, three, and one hour prior to Docefect-RTU 80mg Injection infusion.
Docefect-RTU 80mg Injection, a taxoid-class antineoplastic agent, inhibits cancer cell proliferation and metastasis.
Docefect-RTU 80mg Injecti...
6,464
MRP 7,500
13% off